Clinical Trial Update: Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

Phase IB trial evaluating gemcitabine, docetaxel, and bevacizumab for soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Sarcoma | Phase 1 | Status: COMPLETED